21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46 - Wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52 - Warehousing, storage, and support activities for transport
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 6 | -2,5 | -6,8 | -167,5 |
EBITDA | 6 | -2,5 | 2,2 | 186,3 |
Short time liabilities | 14,2 | 14,3 | 15 | 5,2 |
Equity capital | -2,2 | -4,8 | -11,6 | -143,1 |
Operating profit (EBIT) | 6 | -2,5 | 2,2 | 186,3 |
Assets | 12 | 9,5 | 3,5 | -63,6 |
Net profit (loss) | 6 | -2,5 | -6,8 | -167,5 |
Cash | 2,6 | 0 | 3 | 5961 |
Net income from sale | 6 | 3 | 9 | 200 |
Liabilities and provisions for liabilities | 14,2 | 14,3 | 15 | 5,2 |
Working assets | 11,6 | 9,5 | 3,5 | -63,6 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -273,2 | 53,5 | 58,9 | 5,4 |
Equity capital to total assets | -18,5 | -49,8 | -332,7 | -282,9 |
Gross profit margin | 100,6 | -84,8 | -75,6 | 9,2 |
EBITDA Margin | 100,6 | -84,8 | 24,4 | 109,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 863 | 1739 | 610 | -1129 |
Current financial liquidity indicator | 0.8181143403053284 | 0.6674342751502991 | 0.23108723759651184 | -0,5 |
Net dept to EBITDA | -0.4307266175746918 | 0.01934756152331829 | -1.3586750030517578 | -1,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane